12 December 2019

Teun Bousema and Ioannis Sechopoulos each receive an ERC Consolidator Grant of around two million euros. This European research subsidy will enable them to carry out research for the next five years.

Teun Bousema
Teun Bousema is professor of Epidemiology of Tropical Infectious Diseases, and an expert in the field of malaria. Malaria is an infectious disease passed on by mosquitoes and people. Transmission of the disease on depends on many factors, such as the mosquito, the person's immune system and the local climate. With this grant, Bousema intends to pioneer research into how many parasites are actually passed on through each mosquito bite and what this means for the distribution of the parasite. His goal is to map out the distribution on an unprecedented scale in various areas in Africa. He will also be mapping out the role of human immunity in the distribution stages of malaria and research the importance of this immunity in relation to attempts to eradicate the disease. The results of this research will provide starting points to further combat this deadly disease.

Ioannis Sechopoulos
Ioannis Sechopoulos is associate professor at the department of Radiology and Nuclear Medicine. He focuses on the imaging of breast cancer through X-ray scans and on methods to improve the images and analyses. With this grant, Sechopoulos intends to develop a new scanning method to detect breast cancer. The ‘4D scan’ should be able to distinguish between various areas within a tumor on the basis of a special breast CT scanner. These areas can show, for instance, how well certain parts of the tumor will respond to different treatments so a tailor-made treatment plan can be drawn up. The system should also be able to determine whether a treatment has been successful enough to avoid the necessity of a surgical procedure.

Recently, Sechopoulos was awarded another project by the NWO, called aiREAD. From January 2020, he will be using artificial intelligence to improve the reading of mammograms.
https://www.nwo.nl/onderzoek-en-resultaten/programmas/ttw/partnership/17912.html
 

Related news items


Prinses Beatrix Spierfonds grant to investigate patient stratification in myotonic dystrophy

24 January 2020

Rick Wansink and Roland Brock, both theme Nanomedicine, received a € 280,000 grant from the Prinses Beatrix Spierfonds.

read more

RIMLS PhD retreat registration is open

23 January 2020

Yearly, RIMLS PhD candidates gather for the two-day PhD Retreat. Apart from the science, this event is highly valued for the opportunity to meet and get to know fellow PhD candidates during the social activities. Early bird registration and abstract submission deadline: 4 March 2020.

read more

Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment

23 January 2020

In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.

read more

6 million euros to uncover link between metabolic and brain disorders

21 January 2020

An important European-funded initiative, coordinated by Radboudumc researchers Barbara Franke, Jan Buitelaar, and Janita Bralten, has been launched to explore how common molecular mechanisms may link metabolic disorders with brain disorders.

read more

NWO Open Competition Domain Science - XS grant for Ronald van Rij and Jenny van der Wijst

21 January 2020

NWO Domain Science has awarded Ronald van Rij, theme Infectious diseases and global health and Jennny van der Wijst, theme Renal disorders an XS grant. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea.

read more

First BeNeFit funding granted for psoriasis

17 January 2020

RIHS researchers Elke de Jong and Juul van den Reek of Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

read more